Human Papillomavirus Burden in Different Cancers in Iran: a Systematic Assessment

被引:31
|
作者
Jalilvand, Somayeh [1 ]
Shoja, Zabihollah [2 ]
Hamkar, Rasool [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[2] Pasteur Inst Iran, Tehran, Iran
关键词
Human papillomaviruses; prevalence; HPV types; cancer types; Iran; SQUAMOUS-CELL CARCINOMA; RISK HUMAN-PAPILLOMAVIRUS; LUNG-CANCER; CERVICAL-CANCER; HPV INFECTIONS; PAP-SMEAR; TP53; GENE; PREVALENCE; VIRUS; WOMEN;
D O I
10.7314/APJCP.2014.15.17.7029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Certain types of human papillomaviruses (HPVs) are undoubtedly involved in genesis of human malignancies. HPV plays an etiological role in cervical cancer, but also in many vaginal, vulvar, anal and penile cancers, as well as head and neck cancers. In addition, a number of non-malignant diseases such as genital warts and recurrent respiratory papillomatosis are attributable to HPV. Moreover, HPV forms have detected in several other cancers including esophageal squamous cell carcinoma, lung, prostate, ovarian, breast, skin, colorectal and urinary tract cancers, but associations with etiology in these cases is controversial. The aim of this systematic assessment was to estimate the prevalence of HPV infection and HPV types in HPV-associated cancers, HPV-related non-malignant diseases and in cancers that may be associated with HPV in Iran. The present investiagtion covered 61 studies on a variety of cancers in Iranian populations. HPV prevalence was 77.5 % and 32.4% in cervical cancer and head and neck cancers, respectively. HPV was detected in 23.1%, 22.2%, 10.4%, 30.9%, 14% and 25.2% of esophageal squamous cell, lung, prostate, urinary tract cancers, breast and skin cancers, respectively. HPV16 and 18 were the most frequent HPV types in all cancers. The findings of present study imply that current HPV vaccines for cervical cancer may decrease the burden of other cancers if they are really related to HPV.
引用
收藏
页码:7029 / 7035
页数:7
相关论文
共 50 条
  • [31] Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review
    Niccolai, Linda M.
    Johnson, Nicholaus P.
    Torres, Ashlynn
    Sullivan, Erin L.
    Hansen, Caitlin E.
    JOURNAL OF ADOLESCENT HEALTH, 2023, 72 (03) : 334 - 343
  • [32] Methodological Assessment in a Systematic Review for Anal Human Papillomavirus Among Men
    Taskin, Tanjila
    Gbadamosi, Semiu O.
    Kiplagat, Sandra
    Dawit, Rahel
    Madhivanan, Purnima
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (08): : 1388 - 1388
  • [33] National Trends in Human Papillomavirus Awareness and Knowledge of Human Papillomavirus-Related Cancers
    Wheldon, Christopher W.
    Krakow, Melinda
    Thompson, Erika L.
    Moser, Richard P.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2019, 56 (04) : E117 - E123
  • [34] A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix
    Castle, Philip E.
    Pierz, Amanda
    Stoler, Mark H.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 422 - 429
  • [35] Human papillomavirus as a driver of head and neck cancers
    Sabatini, Maria Elisa
    Chiocca, Susanna
    BRITISH JOURNAL OF CANCER, 2020, 122 (03) : 306 - 314
  • [36] Human Papillomavirus-related Cancers and Mitochondria
    Cruz-Gregorio, Alfredo
    Aranda-Rivera, Ana Karina
    Pedraza-Chaverri, Jose
    VIRUS RESEARCH, 2020, 286
  • [37] HUMAN PAPILLOMAVIRUS AND ANOGENITAL CANCERS IN NORTHERN BRAZIL
    DEMELLO, WA
    DEBARROS, VLRS
    RIBEIRO, MRP
    RAHAL, P
    VILLA, LL
    MACEDO, JE
    LINHARES, AC
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1992, 87 (03): : 445 - 447
  • [38] Cervical Cancers After Human Papillomavirus Vaccination
    Beller, Uziel
    Abu-Rustum, Nadeem R.
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (02): : 550 - 552
  • [39] Cervical Cancers After Human Papillomavirus Vaccination
    Castle, Philip
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (01): : 174 - 174
  • [40] Prevention of Human Papillomavirus-Associated Cancers
    Dillner, Joakim
    SEMINARS IN ONCOLOGY, 2015, 42 (02) : 272 - 283